Mankind Pharma | Sustainability Performance
Pharmaceutical company engaged in the development, manufacture, and marketing of medicines and healthcare products.
1991
India
10,001+ employees
Pharmaceuticals
$1B - 10B in revenue
$100M - 500M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#9119
Overallⓘ#275
in Indiaⓘ#221
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Environmental
Carbon emissionsEnergy consumptionWaste ManagementWater ManagementAir & land impactNature and biodiversitySocial
ExternalitiesGovernance
SDG ImpactFinancial Data
Business performanceCapital & innovationAnalyst projections
Critical
Laggard
Intensity
Energy consumption (direct) intensity (MWh /$M)
Water consumption intensity (m³ /$M)
Industry Benchmark
55.8
B/M 42.0
208.6
B/M 131.1
Powered by illuminem and GIST Impact
Controversy level
- Mankind Pharma Limited, Indian major generic/branded generic pharma, has faced sustained Indian CDSCO and US FDA enforcement scrutiny including the contested 2024 US FDA Form 483 observations at the Sikkim and Vizag production facilities, plus the contested 2023 USD 1 billionplus Mankind Pharma IPO disclosure scrutiny affecting Indian institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.